QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
OTCMKTS:GTHP

Guided Therapeutics (GTHP) Stock Forecast, Price & News

$0.16
+0.06 (+51.33%)
(As of 05:34 PM ET)
Compare
Today's Range
$0.09
$0.16
50-Day Range
$0.11
$0.28
52-Week Range
$0.06
$0.60
Volume
20,026 shs
Average Volume
24,855 shs
Market Capitalization
$8.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GTHP stock logo

About Guided Therapeutics (OTCMKTS:GTHP) Stock

Guided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. It also focuses on the selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The company was founded by Shabbir Bakir Bambot and Mark L. Faupel on October 27, 1992 and is headquartered in Norcross, GA.

Receive GTHP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GTHP Stock News Headlines

Unlock Profit Potential: Find Hidden Trade Opportunities Using A.I.
There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Company Profile for Guided Therapeutics, Inc.
See More Headlines

GTHP Price History

GTHP Company Calendar

Today
6/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GTHP
Employees
6
Year Founded
N/A

Profitability

Net Income
$-4,340,000.00
Net Margins
-4,276.71%
Pretax Margin
-15,676.67%

Debt

Sales & Book Value

Annual Sales
$10,000.00
Book Value
($0.12) per share

Miscellaneous

Free Float
16,920,000
Market Cap
$5.55 million
Optionable
Not Optionable
Beta
0.62

Key Executives

  • Mark L. Faupel
    President, Chief Executive Officer & Director
  • Richard L. Fowler
    Senior Vice President-Engineering













GTHP Stock - Frequently Asked Questions

How have GTHP shares performed in 2023?

Guided Therapeutics' stock was trading at $0.30 on January 1st, 2023. Since then, GTHP shares have decreased by 63.7% and is now trading at $0.1089.
View the best growth stocks for 2023 here
.

Are investors shorting Guided Therapeutics?

Guided Therapeutics saw a drop in short interest in May. As of May 15th, there was short interest totaling 7,700 shares, a drop of 56.7% from the April 30th total of 17,800 shares. Based on an average daily trading volume, of 118,100 shares, the days-to-cover ratio is currently 0.1 days.
View Guided Therapeutics' Short Interest
.

What is Guided Therapeutics' stock symbol?

Guided Therapeutics trades on the OTCMKTS under the ticker symbol "GTHP."

How do I buy shares of Guided Therapeutics?

Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Guided Therapeutics' stock price today?

One share of GTHP stock can currently be purchased for approximately $0.11.

How much money does Guided Therapeutics make?

Guided Therapeutics (OTCMKTS:GTHP) has a market capitalization of $5.55 million and generates $10,000.00 in revenue each year.

How can I contact Guided Therapeutics?

Guided Therapeutics' mailing address is 5835 PEACHTREE CORNERS EAST SUITE D, PEACHTREE CORNERS GA, 30092. The official website for the company is www.guidedinc.com. The company can be reached via phone at (770) 242-8723, via email at bwells@guidedinc.com, or via fax at 770-242-8639.

This page (OTCMKTS:GTHP) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -